We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use ÌìÃÀÓ°Ôº, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Data on gifts and hospitality received by special advisers, and meetings they attended with senior media figures.
All data on senior officials’ business expenses, external meetings and hospitality.
Data on ministers' external meetings and any overseas travel.
Summaries of advice given under the business appointment rules to applicants at SCS2 and SCS1 level and equivalents.
Details of seminars hosted by the UK National Screening Committee.
The strategy will set the direction for how we will invest in and transform the use of pathogen genomics in response to infectious public health threats.
These reports outline the MHRA’s Corporate and Business Plans, detailing the agency's strategic direction over the next three years.
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
MHRA transactions over £500 made using the government procurement card (GPC).
Agenda and draft minutes for the UK National Screening Committee meeting on 27 March 2025.
The register of interests of members of the Independent Reconfiguration Panel (IRP).
Agenda of the UK National Screening Committee meeting on 26 June 2025.
The public appointments, personal and business interests, and political activity of members of the Council for Science and Technology.
Reports on departmental staff numbers and costs.
Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.
An ad hoc publication summarising the volume of Bounce Back loans (BBL) held by dissolved or liquidated companies.
Notes from the May 2025 meeting of the UK National Screening Committee blood spot task group.
The latest quarterly update of data on the performance of the government’s COVID-19 loan guarantee schemes. Data as at March 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve ÌìÃÀÓ°Ôº, we’d like to know more about your visit today. .